US$ 25.42
are glp 1 a peptide Glucagon Like Receptor - an overview GLP-1 vs. Peptide Therapy: What's
Description
doi: 10.1111/j.1365-2982.2007.01079.x

Klebanoff: Even with lower negotiated prices, prior authorization may block access to GLP-1s for both obesity and diabetes, even for patients who are clinically eligible for treatment

And the smart money is already adapting
Management Strategies for GLP-1 Side Effects To minimize discomfort, patients can follow these practical strategies: 1

Some plans require step therapy, which forces patients to prove that less expensive medications were ineffective before they cover more costly ones
